	普通株資本		日付
Acadia Pharmaceuticals	USD 169.18M	470K	2025-12
Adma Biologics	USD 237.88M	457K	2025-12
ALKERMES	USD 165.61M	503K	2025-12
Alterity Therapeutics Limited	AUD 213.97M	144.39K	2023-06
AstraZeneca	USD 1.55B	206K	2025-12
BioCryst Pharmaceuticals	USD 213.06M	2.54M	2025-12
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Cipla	INR 807.77M	807.43M	2025-09
Clal Biotechnology	ILS 1.61M	0	2022-12
Compugen	USD 94.55M	1.02M	2025-12
CSL	USD 482.13M	93.87M	2025-12
Eli Lilly	USD 946.83M	354.23M	2025-06
Esperion Therapeutics	USD 245.22M	39.79M	2025-12
GlaxoSmithKline	GBP 4.08B	49.43M	2025-12
Grifols	EUR 680.58M	846.11K	2025-12
Halozyme Therapeutics	USD 117.78M	259K	2025-12
Ionis Pharmaceuticals	USD 161.97M	836K	2025-12
J&J	USD 2.41B	584K	2025-09
Merck	USD 2.49B	15.79M	2025-09
Minerva Neurosciences	USD 1000	0	2024-09
Neurocrine Biosciences	USD 100.1M	400K	2025-12
Novartis	USD 1.91B	10.64M	2025-12
Novavax	USD 162.58M	106K	2025-12
Pfizer	USD 5.69B	1000K	2025-09
Roche Holding	CHF 795.62M	699.54K	2025-12
Takeda	JPY 1.58B	2K	2025-12
Vanda Pharmaceuticals	USD 58K	0	2024-12